Brought to you by:
FDA approves dissection and transection indication expansion for RelayPro stent graft system
Terumo Aortic announced that the Food and Drug Administration (FDA) has granted approval of the RelayPro thoracic stent graft device for the treatment of dissection and transection in the U.S. A Terumo Aortic press release notes that RelayPro delivers uncompromised…
Terumo Aortic announces first commercial implants of RelayPro in US
Terumo Aortic today announced the first commercial implants in the U.S. of its RelayPro thoracic stent-graft system. This follows the recent approval by the Food and Drug Administration (FDA) of a device designed to treat patients with fusiform and saccular…
RelayPro thoracic stent graft approved by FDA
Terumo Aortic today (Friday, Aug. 6) announced that the Food and Drug Administration (FDA) has granted approval of the RelayPro thoracic stent-graft system for sale in the United States for the treatment of patients with thoracic aortic aneurysms (TAAs) and…